China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
Classifica tra le azioni
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Prezzo delle azioni
$3.74
Capitalizzazione di mercato
$6.23B
Variazione (1 giorno)
-2.11%
Variazione (1 anno)
-8.54%
Paese
CN
Scambia China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Categoria
Healthcare
Utile per China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Utile nel Jun 2026 TTM: $714.70M
Secondo gli ultimi rapporti finanziari di China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., gli utili attuali della società sono $714.70M. Nel 2024, la società ha registrato un utile di $629.34M, un aumento rispetto a agli utili del 2023, che erano di $530.39M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. dal 2001 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $714.70M | 2.80% |
| 2025 | $695.23M | 10.47% |
| 2024 | $629.34M | 18.65% |
| 2023 | $530.39M | 37.94% |
| 2022 | $384.52M | 21.98% |
| 2020 | $315.25M | -14.08% |
| 2019 | $366.92M | 46.83% |
| 2018 | $249.89M | 7.08% |
| 2017 | $233.36M | 11.49% |
| 2016 | $209.31M | -11.11% |
| 2015 | $235.46M | 15.78% |
| 2014 | $203.36M | -9.34% |
| 2013 | $224.32M | 8.45% |
| 2012 | $206.84M | 37.53% |
| 2011 | $150.40M | -4.00% |
| 2010 | $156.66M | 18.25% |
| 2009 | $132.48M | 39.94% |
| 2008 | $94.67M | 79.81% |
| 2007 | $52.65M | 60.01% |
| 2006 | $32.90M | 52.20% |
| 2005 | $21.62M | -126.33% |
| 2004 | $-82.11M | -349.03% |
| 2003 | $32.97M | 44.24% |
| 2002 | $22.86M | 11.09% |
| 2001 | $20.58M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $3.62B | 406.21% |
DE
|
|
| $3.40B | 376.42% |
DE
|
|
| $1.72B | 141.17% |
JP
|
|
| $930.30M | 30.17% |
CH
|
|
| $1.69B | 136.83% |
IN
|
